FDA Drug Application (083770) for HYDROCHLOROTHIAZIDE W/ RESERPINE AND HYDRALAZINE by WATSON LABS

Back to FDA Applications sponsored by WATSON LABS

Application Number083770
Product Number001
FormTABLET;ORAL
Dosage25MG;15MG;0.1MG
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameHYDROCHLOROTHIAZIDE W/ RESERPINE AND HYDRALAZINE
Active IngredientHYDRALAZINE HYDROCHLORIDE; HYDROCHLOROTHIAZIDE; RESERPINE

Active IngredientCount
List of drugs with Active Ingredient HYDRALAZINE HYDROCHLORIDE27
List of drugs with Active Ingredient HYDROCHLOROTHIAZIDE122
List of drugs with Active Ingredient RESERPINE52


Back to FDA Applications sponsored by WATSON LABS